Topic Archives: Pfizer (PFE)

Today I decided to sit down for a while with a teaser ad from Dr. Mark Skousen’s Forecasts & Strategies ($50/year) — this letter is actually from his publisher, Roger Michalski, but it focuses on an idea of Skousen’s that he calls “American X”. So what is this secret “American X” company? It’s apparently got […]

Every now and then a reader sends in a question about one of the stock ideas teased by dividend.com, which is a service that looks for, you guessed it, dividend paying stocks. Their standard “tease” is that they send around some hints about the latest stock they’ve added to one of their “best” lists, but […]

[ed. note: Michael Jorrin, who I dubbed “Doc Gumshoe” years ago, is a longtime medical writer (not a doctor) who writes for us a couple times a month about health issues and trends.  He does not typically write about specific investment opportunities, but has agreed to our trading restrictions… as with all of our authors, […]

[Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trade restrictions, chooses his own topics, and his words and opinions are his own. You can see all his past articles and more recent comments here.] Picture the gurbling fumaroles of Yellowstone: from the late 1990’s and on into […]

[ed note: Michael Jorrin, who I like call “Doc Gumshoe,” is a longtime medical writer who shares his thoughts with us a couple times a month — his articles are non-financial in nature, his words and opinions are his own, and you can see his bio and his past pieces here. Enjoy!] Indulge me while […]

[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though, he mentions a couple publicly traded companies). His words and opinions are his own.] The […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Gumshoe Irregulars. He has agreed to our trading restrictions, he chooses his own topics, and his words and opinions are his own. Enjoy!] OK, admit it….how many of you have seen the campy films of Baltimore director John Waters? The ones starring the […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own, and he has agreed to our trading restrictions.] Want to see something really cool? A hot video clip from a steamy biotech thriller? Watch this. Better yet, when you pull up the video viewing frame, […]

In his tearjerker “Sisters of Mercy,” Leonard Cohen sings, I’ve been where you’re hanging and think I can see how you’re pinned. Although I am less inclined to bash the FDA than many, it has recently let modern medical practice place many patients in an undesirable situation. What if there was a very powerful drug, […]

[ed. note: Dr. KSS writes about biotech stocks for the Irregulars. He has agreed to our trading restrictions, but he chooses his own topics and his words and thoughts are his own] According to new SEC filings, Cellceutix President, co-founder and Chief Scientific Officer Krishna Menon has recently settled what should probably be regarded as […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]

[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Any discussion of cholesterol immediately turns Brobdingnagian, such are the extremes in question. Statins, which lower LDL cholesterol, are bombastically the best-selling drugs of all […]

[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]

Comments

  • Probably be a good idea to compare the largely fictitious phage therapy to the new kid on the block: mRNA delivery to e...

  • Fool is pushing NVX and AZN, with PFE in the mix...

  • I agree, anytime there is a cure, a secret, conspiracy, or a book for sale creates more caution. Greed is writing the ...

  • #Biotech Best turnaround M&A $ARQL 20X $MRK BO in 2yr $ARRY $2s Multiple setbacks ➡️ 20X $PFE BO in 3yr $ECYT...

  • How do you think recent regulation allowing US consumers to purchase Rx's from Canada will impact PFE and other pharmace...

  • Travis ---you're right on-----The five he talks about are: ABBV, PFE, JNJ, MRK amd UNH...

  • FYI: Pfizer earnings were fine, but the guidance for 2019 earnings was lower than analyst estimates (thanks to the stron...

  • Who knows if any of what Shousen says is true but I'm in PFE just because it's a good company and pays a nice dividend. ...

  • Switzerland is divided in three main region where we speak French, German and italian (plus grischun) hence the swiss-it...

  • It's more likely PFE would buy out $AMRN by the end of 2019, and that, folks, would be 100% easy from current levels....

  • It is Italian but operates its partnerships out of Switzerland and has linked up with lots of drug firms besides PFE inc...

  • It is Italian but operates its partnerships out of Switzerland and has linked up with lots of drug firms besides PFE inc...

  • I'll stick to investing in my brother. He's worked for 3 companies that have been acquired by PFE. He stayed for awhil...

  • That’s one of Jimmy Mengel’s recent teases, most of it is a rehash of previous pitches but that new addition of the ...

  • $AKAO Just finished reading the whole transcript of the Conference Call which I would suggest others do, time permitting...

  • Kiplinger makes a case for Pfizer (PFE) in your retirement account. http://www.kiplinger.com/slideshow/investing/T052-S...

  • For those that hold Pfizer (PFE) a good read. http://marketrealist.com/2016/11/pfizers-valuation-compared-to-peers/ ...

  • Pfizer (PFE) launching first mAb copycat at a small discount. http://endpts.com/pfizer-launches-first-us-mab-biosimil...

  • Joe, just wanted to note a couple of basics (and forgive me if you already know these): Do not use stock price as an in...

  • Incyte $INCY looks like a worthy alluring takeover candidate here to me. I suspect it's on a shopping list at both Aller...

  • Pfizer (PFE) blocking its drugs for lethal injections. https://www.yahoo.com/news/pfizer-says-blocking-drugs-lethal-i...

  • Pfizer (PFE) receives a large injection worth of calls. http://www.bottarelliresearch.com/trades/2016/01/28/pfizer-rece...

  • Pfizer (PFE) receives a large injection worth of calls. http://www.bottarelliresearch.com/trades/2016/01/28/pfizer-rece...

  • Pfizer (PFE) with 5 buy ratings in December. http://www.marketbeat.com/stocks/NYSE/PFE/ Cheers,Glenn...

  • Pfizer (PFE) mentioned being dirt cheap in overbought market. http://investorplace.com/2015/11/6-dirt-cheap-stocks-to-b...

  • Good news for Pfizer (PFE) today. http://fda.einnews.com/article/292317732/CSbRUhc0UqlsuELq Cheers,Glenn...

  • Pfizer (PFE) Spends $300 Million on Exploring Possibility of Split http://www.google.ca/url?sa=t&rct=j&q=&esrc=s&sourc...

  • An intersting point of view for you all: May 22, 2015, 1:12 P.M. ET Esperion Therapeutics: 15 Reasons to Take Profit...

  • Was this what the Dr. was forseeing? Introducing PfizerKline: Analyst Makes New Case for Merger of GlaxoSmithKline (GSK...

  • Pfizer (PFE) to make a play on Shire plc ? http://www.nasdaq.com/article/could-this-dark-horse-be-pfizer-incs-next-majo...

  • Well here's another M&A rumor from SA regarding PFE... -According to Reuters, Pfizer (PFE +0.2%) is negotiating a tak...

  • For those of you either owning or considering big Pharma companies here is an article on Patent Expiration for you to co...

  • I promised those of you that asked I'd get back here and tell you what are the three stocks I have a bead on to buy with...

  • By October 3, 2013, the U.S. Food and Drug Administration (FDA) will decide whether to approve Ligand Pharmaceutical's (...

  • Entfor drips there is pfizer pfe its a guarenteed winner thouh not in the near future w// the money they have and experi...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info